News

Santé log1h
Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening
Compounds developed through collaboration with Variational AI show targeted activity VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the ...
Santé log1h
Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer’s disease
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid pathology. The minimally invasive, blood-based test can serve as a rule out ...
Santé log1h
Ipsen announces changes to its Executive Committee
PARIS, FRANCE, 23 July 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care biopharmaceutical company, today announced the following changes to its Executive Committee: Mari, Andreas and ...
Santé log17h
100,000 Customers Choose Hemp Hop As Their Go-To Place to Buy THCa Flower
More people now search for the best place to buy THCa flower, and Hemp Hop stands out because the numbers and practices back ...
Santé log4h
European Commission approves Roche’s Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation
Up to 40% of ER-positive breast cancers have a PIK3CA mutation and are associated with poor prognosis; this approval helps address an urgent unmet need2-4 Basel, 23 July 2025 - Roche (SIX: RO, ROG; ...
Santé log4h
Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences
H.C. Wainwright 27th Annual Global Investment Conference Date: September 8-10, 2025 Location: New York, NY About Eupraxia Pharmaceuticals Inc.
Santé log4h
Solera Health Expands Capabilities in Insights Through Unique Machine Learning Predictive Models – Driving Improvements in Care Outcomes and Costs
New Solera Precision Insights Suite Improving the Accuracy of Predictive Modeling in Healthcare. PHOENIX, July 22, 2025 (GLOBE NEWSWIRE) -- Solera Health, a premier digital health ...
Santé log4h
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy
Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced that it has initiated a strategic ...
Santé log4h
Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 ...
Santé log4h
HMNC Brain Health and Spruce Biosciences Announce First Patient Dosed in Phase 2 TAMARIND Trial For Major Depressive Disorder
Study Initiation Marks Key Milestone in Advancing Precision Psychiatry Treatment for Major Depressive Disorder MUNICH, Germany and SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- HMNC ...
Santé log4h
Betterguards Forms Strategic Alliance with NBATA to Accelerate Injury Prevention & Recovery Innovation
Next-generation sports tech innovator teams up with NBATA to advance product testing, research, and development. NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Betterguards, a sports ...
Santé log4h
Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)
Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will replace the non-voting equity securities (Genussscheine). Reduction of the nominal value of the bearer ...